World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 116 4283 4013 419 400 548 66586
Molecular Biology 112 336 306 23 22 450 58518

J. Carl Barrett publications per year

The chart shows the history of publications by J. Carl Barrett between 1966 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. J. Carl Barrett published across 60 years, from 1966 to 2025, averaging 9.8 papers a year. Output peaked at 33 publications in 2004. 7 of the 586 publications appeared in the last two years.

No. of publications
10 20 30
Bar chart. Horizontal axis: year, 1966 to 2025. Vertical axis: number of publications, 0 to 33. Peak 33 publications in 2004. 1966: 1 publication 1967: 0 publications 1968: 0 publications 1969: 0 publications 1970: 0 publications 1971: 0 publications 1972: 0 publications 1973: 0 publications 1974: 2 publications 1975: 0 publications 1976: 1 publication 1977: 2 publications 1978: 7 publications 1979: 4 publications 1980: 3 publications 1981: 5 publications 1982: 5 publications 1983: 8 publications 1984: 6 publications 1985: 12 publications 1986: 8 publications 1987: 3 publications 1988: 4 publications 1989: 6 publications 1990: 6 publications 1991: 10 publications 1992: 10 publications 1993: 15 publications 1994: 18 publications 1995: 14 publications 1996: 12 publications 1997: 22 publications 1998: 25 publications 1999: 16 publications 2000: 16 publications 2001: 25 publications 2002: 24 publications 2003: 26 publications 2004: 33 publications 2005: 27 publications 2006: 14 publications 2007: 7 publications 2008: 8 publications 2009: 9 publications 2010: 5 publications 2011: 3 publications 2012: 1 publication 2013: 6 publications 2014: 9 publications 2015: 12 publications 2016: 15 publications 2017: 18 publications 2018: 19 publications 2019: 13 publications 2020: 16 publications 2021: 17 publications 2022: 1 publication 2023: 30 publications 2024: 3 publications 2025: 4 publications
1966 2025

586 publications in total across all disciplines

View publications per year as a table
J. Carl Barrett: publications per year, 1966 to 2025
Year Publications
1966 1
1967 0
1968 0
1969 0
1970 0
1971 0
1972 0
1973 0
1974 2
1975 0
1976 1
1977 2
1978 7
1979 4
1980 3
1981 5
1982 5
1983 8
1984 6
1985 12
1986 8
1987 3
1988 4
1989 6
1990 6
1991 10
1992 10
1993 15
1994 18
1995 14
1996 12
1997 22
1998 25
1999 16
2000 16
2001 25
2002 24
2003 26
2004 33
2005 27
2006 14
2007 7
2008 8
2009 9
2010 5
2011 3
2012 1
2013 6
2014 9
2015 12
2016 15
2017 18
2018 19
2019 13
2020 16
2021 17
2022 1
2023 30
2024 3
2025 4
Total 586
Download as CSV

J. Carl Barrett publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where J. Carl Barrett sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 53 bars. Horizontal axis: publications, 47–56 to 564+. Vertical axis: number of scientists, 0 to 177. Most scientists, 177, have 117–126 publications. The last bar groups every scientist with 564 publications or more. The highlighted bar, 447–456 publications, is where this scientist sits. 47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47–56 publications 564+

This scientist: 450 publications — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

View publications distribution as a table
Number of Molecular Biology scientists by publication count, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
Publications Scientists This scientist
47–56 7
57–66 17
67–76 65
77–86 90
87–96 125
97–106 131
107–116 162
117–126 177
127–136 158
137–146 158
147–156 146
157–166 159
167–176 131
177–186 110
187–196 112
197–206 100
207–216 89
217–226 98
227–236 74
237–246 72
247–256 63
257–266 53
267–276 54
277–286 49
287–296 52
297–306 43
307–316 46
317–326 41
327–336 42
337–346 31
347–356 28
357–366 29
367–376 26
377–386 24
387–396 24
397–406 14
407–416 13
417–426 20
427–436 12
437–446 20
447–456 11 450
457–466 10
467–476 14
477–486 14
487–496 10
497–506 13
507–516 13
517–526 2
527–536 4
537–546 6
547–556 8
557–563 6
564+ 100
Download as CSV

J. Carl Barrett D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where J. Carl Barrett sits on this spectrum.

No. of scientists
25 50 75 100 125
Bar chart with 54 bars. Horizontal axis: D-Index, 40–41 to 145+. Vertical axis: number of scientists, 0 to 131. Most scientists, 131, have 64–65 D-Index. The last bar groups every scientist with 145 D-Index or more. The highlighted bar, 112–113 D-Index, is where this scientist sits. 40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40–41 D-Index 145+

This scientist: 112 D-Index — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

View D-Index distribution as a table
Number of Molecular Biology scientists by D-index, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
D-Index Scientists This scientist
40–41 36
42–43 101
44–45 115
46–47 121
48–49 118
50–51 130
52–53 106
54–55 116
56–57 113
58–59 129
60–61 120
62–63 105
64–65 131
66–67 95
68–69 97
70–71 106
72–73 83
74–75 89
76–77 77
78–79 70
80–81 73
82–83 60
84–85 48
86–87 45
88–89 50
90–91 31
92–93 51
94–95 43
96–97 38
98–99 39
100–101 41
102–103 29
104–105 33
106–107 35
108–109 20
110–111 38
112–113 19 112
114–115 28
116–117 13
118–119 23
120–121 16
122–123 15
124–125 11
126–127 21
128–129 7
130–131 13
132–133 14
134–135 17
136–137 9
138–139 8
140–141 16
142–143 7
144 7
145+ 100
Download as CSV

Overview

J. Carl Barrett is affiliated with AstraZeneca in the United Kingdom and has contributed extensively to the fields of medicine, biochemistry, genetics, and molecular biology. Their research spans multiple subfields including molecular biology, oncology, cardiology and cardiovascular medicine, radiology, nuclear medicine and imaging, as well as pulmonary and respiratory medicine. Barrett's work encompasses a range of topics predominantly focused on cancer research and molecular diagnostics.

The scientist's research areas include:

  • HER2/EGFR in Cancer Research
  • Advanced Biosensing Techniques and Applications
  • Monoclonal and Polyclonal Antibodies Research
  • Cancer Genomics and Diagnostics
  • BRCA gene mutations in cancer
  • DNA Repair Mechanisms
  • Cell Adhesion Molecules Research

Barrett's publication record features papers in several notable scientific venues. Frequent publication outlets include:

  • Cancer Research
  • PLOS Digital Health
  • Scientific Reports
  • Molecular Oncology
  • Journal of Visualized Experiments

Among recent publications are:

  • Abstract PD6-01: Novel approach to HER2 quantification: Digital pathology coupled with AI-based image and data analysis delivers objective and quantitative HER2 expression analysis for enrichment of responders to trastuzumab deruxtecan (T-DXd; DS-8201), specifically in HER2-low patients, 2021, Cancer Research
  • HER2 quantitative continuous scoring for accurate patient selection in HER2 negative trastuzumab deruxtecan treated breast cancer, 2024, Scientific Reports
  • Serial monitoring of genomic alterations in circulating tumor cells of ER-positive/HER2-negative advanced breast cancer: feasibility of precision oncology biomarker detection, 2021, Molecular Oncology
  • Insights from a single centre implementation of a digitally-enabled atrial fibrillation virtual ward, 2024, PLOS Digital Health
  • Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis, 2021, Journal of Visualized Experiments

Barrett frequently collaborates with a consistent group of co-authors, indicating interdisciplinary teamwork in their research efforts. These co-authors include Hadassah Sade, Ansh Kapil, Sadia Khan, Susanne Haneder, and Ana Hidalgo-Sastre.

Best Publications

  • A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

    Yoshio Miki;Jeff Swensen;Donna Shattuck-Eidens;P. Andrew Futreal

  • Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability

    Asad Umar;C. Richard Boland;Jonathan P. Terdiman;Sapna Syngal

  • Genomic Instability and Aging-like Phenotype in the Absence of Mammalian SIRT6

    Raul Mostoslavsky;Katrin F. Chua;Katrin F. Chua;David B. Lombard;Wendy W. Pang

  • Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins.

    Eriko Michishita;Jean Y. Park;Jenna M. Burneskis;J. Carl Barrett

  • Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: A preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial

    Jonathan Ledermann;Philipp Harter;Charlie Gourley;Michael Friedlander

  • Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M

    Kenneth S Thress;Cloud P Paweletz;Enriqueta Felip;Byoung Chul Cho

  • GoMiner: a resource for biological interpretation of genomic and proteomic data

    Barry R Zeeberg;Weimin Feng;Geoffrey Wang;May D Wang

  • SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin

    Eriko Michishita;Ronald A. McCord;Elisabeth Berber;Mitomu Kioi

  • Microarrays and toxicology: the advent of toxicogenomics.

    Emile F. Nuwaysir;Michael Bittner;Jeffrey Trent;J. Carl Barrett

  • Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks

    Olga A. Sedelnikova;Izumi Horikawa;Drazen B. Zimonjic;Nicholas C. Popescu

  • Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non–Small-Cell Lung Cancer

    Geoffrey R. Oxnard;Kenneth S. Thress;Ryan S. Alden;Rachael Lawrance

  • HIF‐1α induces cell cycle arrest by functionally counteracting Myc

    Minori Koshiji;Yukio Kageyama;Erin A Pete;Izumi Horikawa

  • VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research

    Zhongwu Lai;Aleksandra Markovets;Miika Ahdesmaki;Brad Chapman

  • Calorie Restriction, Aging, and Cancer Prevention: Mechanisms of Action and Applicability to Humans*

    Stephen D. Hursting;Jackie A. Lavigne;David Berrigan;Susan N. Perkins

  • Clinical proteomics: translating benchside promise into bedside reality

    Emanuel F. Petricoin;Kathryn C. Zoon;Elise C. Kohn;J. Carl Barrett

  • Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial

    Amit M Oza;David Cibula;Ana Oaknin Benzaquen;Christopher Poole

  • Gene expression analysis reveals chemical-specific profiles.

    Hisham K. Hamadeh;Pierre R. Bushel;Supriya Jayadev;Karla Martin

  • Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer.

    Kristin K. Zorn;Tomas Bonome;Lisa Gangi;Gadisetti V.R. Chandramouli

  • EGFR mutation detection in ctDNA from NSCLC patient plasma: A cross-platform comparison of leading technologies to support the clinical development of AZD9291

    Kenneth S. Thress;Roz Brant;T. Hedley Carr;Simon Dearden

  • Osimertinib As First-Line Treatment of EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer.

    Suresh S. Ramalingam;James C.-H. Yang;Chee Khoon Lee;Takayasu Kurata

Frequent Co-Authors

Mitsuo Oshimura
Mitsuo Oshimura Tottori University
Stephen D. Hursting
Stephen D. Hursting University of North Carolina at Chapel Hill
Cynthia A. Afshari
Cynthia A. Afshari Janssen (United States)
Andrew Berchuck
Andrew Berchuck Duke University
Vladimir Larionov
Vladimir Larionov National Institutes of Health
John T. Isaacs
John T. Isaacs Johns Hopkins University
John A. McLachlan
John A. McLachlan Tulane University
P. Andrew Futreal
P. Andrew Futreal The University of Texas MD Anderson Cancer Center
Jonathan A. Ledermann
Jonathan A. Ledermann University College London
Paul Nettesheim
Paul Nettesheim National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Molecular Biology in the USA opens doors to a diverse range of health science and medical careers. For students interested in expanding their impact or pursuing patient care, many transition to advanced nursing pathways. Understanding how long to become nurse practitioner is important for setting realistic goals and planning your educational journey.

There are several fast-track options for those with previous credentials or a related science background. For registered nurses seeking further qualification, completing a rn to bsn in 6 months program is a popular choice, offering an accelerated route to broaden career opportunities.

Graduates of associate degree programs can consider asn to fnp programs that bridge the gap to advanced practice and leadership roles. Additionally, individuals from non-nursing backgrounds can access direct entry msn programs for non nurses online to quickly jumpstart a new career in healthcare.

Exploring these online degrees and pathways allows Molecular Biology graduates to leverage their scientific knowledge in clinical, research, and allied health environments, often with the flexibility to study while working.

Best Scientists Citing J. Carl Barrett

Trending Scientists

Recently Published Articles